i.ilunga

TL2 · Plovdiv

Contributes reviews on supplier material. Based in Plovdiv.

Joined 18 August 2025 · last posted 1h

89 posts, newest first. Showing up to 150.

Where to report an adverse event officially, by region Replied, post #3 · marked as the solution · Safety › Adverse events · 28 Jul 2026 · 7 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Interactions with other medicines are a common contributor to events…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #65 · Compounds › Secretagogues & GH axis · 27 Jul 2026 · 0 likes Reading a rodent study is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Hair shedding at month three: mechanism and time course — the long version Replied, post #47 · Practice › Side effects · 15 Jul 2026 · 0 likes Post #43 put the caveat in the right place and I want to underline it. Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #33 · Practice › Interactions · 11 Jul 2026 · 25 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #95 · Compounds › Semaglutide · 7 Jul 2026 · 11 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #35 · Pharmacology › Receptor biology · 4 Jul 2026 · 0 likes Signalling through cyclic AMP is the canonical pathway and is not the only one. Beta-arrestin recruitment differs between ligands and its clinical significance here is…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #77 · Analytics › Method validation · 4 Jul 2026 · 0 likes Answering the question post #73 raises rather than the one it answers. On Specificity, I would rather understate and be corrected upward than overstate and be quoted.…
What a reversed-phase purity number actually is Replied, post #15 · Analytics › HPLC & UHPLC · 1 Jul 2026 · 2 likes That is the distinction I keep failing to hold on to. Written down now.
Personal or family history of medullary thyroid carcinoma Replied, post #16 · Safety › Contraindications · 26 Jun 2026 · 17 likes Post #12 describes the usual case. This is about the unusual one. Disordered eating history: appetite suppression can trigger relapse in people with history of…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #53 · Start Here › How to Ask · 19 Jun 2026 · 1 like Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #5 · Clinical › Comorbidities · 17 Jun 2026 · 20 likes Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote. Reading it back, the second half…
Follow-up: Reading an interaction checker output critically Replied, post #7 · Practice › Interactions · 16 Jun 2026 · 21 likes Absence of an interaction study is not evidence of no interaction. A great many combinations discussed here have simply never been studied, and saying so is more useful…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #16 · Access › International · 15 Jun 2026 · 0 likes On post #12 — agreed on the reasoning, with one qualification. The most useful thing anyone can add to a thin regional thread is what the official source says and where…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #78 · Evidence › Preprints · 13 Jun 2026 · 31 likes The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting. Anyone with a larger…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #26 · Sourcing › Independent verification · 12 Jun 2026 · 0 likes Where the Janoshik discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #22 · Analytics › HPLC & UHPLC · 11 Jun 2026 · 9 likes I would rather this thread reach "we do not know" about Carryover than reach a confident answer that nobody can support when asked.
Does a peptide degrade silently, with no visual change? Replied, post #45 · Practice › Storage & stability · 10 Jun 2026 · 6 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #59 · Sourcing › Red flags · 5 Jun 2026 · 20 likes The arithmetic in post #58 is right; the assumption feeding it is the part to check. A certificate that reports a specification in the result column is a documentation…
Blind submission and why it changes minds — the long version Replied, post #106 · Sourcing › Independent verification · 29 May 2026 · 0 likes Reading back through the Blind submission threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #48 · Practice › Reconstitution · 11 May 2026 · 2 likes Second this, and I would have said it less carefully.
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #2 · Compounds › Semaglutide · 19 Apr 2026 · 10 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #75 · Research Methods › Statistics · 11 Apr 2026 · 15 likes I had written a reply contradicting post #73 and deleted it. Here is what survived. Measurement error in home scales sits at the boundary between what this community…
Constipation management, with a dietitian's contribution Replied, post #51 · Practice › Side effects · 11 Apr 2026 · 1 like Adding the boring version of constipation management, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #28 · Sourcing › Red flags · 9 Apr 2026 · 0 likes Practical experience of supplier, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.
Second pass at: What pooling buys you and what it destroys Replied, post #34 · Evidence › Meta-analyses · 4 Apr 2026 · 0 likes The version of pooling buys that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and…
How to tell whether your question is already answered on a maintained page Replied, post #9 · Start Here › Welcome · 3 Apr 2026 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #42 · Data & Tools › Datasets · 25 Mar 2026 · 20 likes Clear enough that I do not think I have a follow-up, which is unusual.
[2026 update] Thyroid function tests during substantial weight change Replied, post #21 · Clinical › Bloodwork · 23 Mar 2026 · 2 likes Second this, and I would have said it less carefully.
Splitting an overlong document into two Replied, post #9 · Documentation › Wiki requests · 23 Mar 2026 · 29 likes Thank you for taking the time. That was more work than a reply usually is.
Second pass at: Metformin co-administration and additive GI effects Replied, post #71 · Practice › Interactions · 22 Mar 2026 · 0 likes Practical experience of Metformin co-administration, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #92 · Research Methods › N-of-1 designs · 22 Mar 2026 · 20 likes A single-person experiment can be genuinely informative if it has a pre-specified outcome, a defined period, and a plan written before the data arrives. Most accounts…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #19 · Evidence › Journal club · 18 Mar 2026 · 3 likes Genuine question rather than a rhetorical one: has anyone here actually observed orforglipron phase 2, as opposed to read about it? The thread is long and I cannot tell.
An ABAB design with a data table and honest limitations — a second dataset Replied, post #73 · Research Methods › N-of-1 designs · 17 Mar 2026 · 22 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
[2026 update] Distinguishing expected GI effects from something that needs urgent… Started this topic · Practice › Side effects · 9 Mar 2026 · 21 likes On the subject in the title: Distinguishing expected GI effects from something that needs urgent attention Working notes rather than a conclusion. Reporting something…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #45 · Analytics › Impurities & related substances · 26 Feb 2026 · 18 likes Building on post #44 rather than restating it. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass…
Interpreting a result that disagrees with the supplier's certificate Replied, post #138 · Sourcing › Independent verification · 25 Feb 2026 · 28 likes Adding thanks rather than a view. I do not have a view worth the space.
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #43 · Practice › Dosing & titration · 17 Feb 2026 · 14 likes Answering the question post #39 raises rather than the one it answers. Research-use-only material is not a licensed product and no labelling covers it. Everything in…
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #8 · Evidence › Journal club · 17 Feb 2026 · 2 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #2 · Analytics › HPLC & UHPLC · 20 Jan 2026 · 27 likes I read the opening post twice before replying, because I had assumed the opposite. Area percent is a proportion of absorbance, not a proportion of mass. Two species…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #37 · Practice › Side effects · 20 Jan 2026 · 4 likes Building on post #34 rather than restating it. The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from…
The most useful thing you learned here that was not the answer you came for Replied, post #15 · Lounge › Off topic · 19 Jan 2026 · 5 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute. If it helps: the…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #111 · Analytics › COA interpretation · 15 Jan 2026 · 13 likes Post #109 and I disagree about the size of the effect, not about the direction. A chromatogram supplied as a small image is legible for peak shape and not for baseline…
Vomiting: when it is expected and when it is a reason to stop Replied, post #22 · Practice › Side effects · 27 Dec 2025 · 1 like The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Heterogeneity as information rather than as a nuisance Replied, post #19 · Evidence › Meta-analyses · 8 Dec 2025 · 22 likes Taking heterogeneity seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #84 · Practice › Reconstitution · 20 Nov 2025 · 23 likes Swirling until fully clear before drawing is worth the extra minute. A partially dissolved preparation is not uniform and the first dose out of it is not the same as…
Prescription requirements and telehealth models Replied, post #9 · Sourcing › Regulatory · 11 Nov 2025 · 8 likes Post #5 describes the usual case. This is about the unusual one. Where the prescription requirements and telehealth models reasoning breaks down for me is the step from…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #27 · Compounds › Tirzepatide · 9 Nov 2025 · 4 likes Post #26 put the caveat in the right place and I want to underline it. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is…
Sleep tracking data and its considerable limitations Replied, post #124 · Wellbeing › Sleep · 29 Oct 2025 · 2 likes Post #122 and I disagree about the size of the effect, not about the direction. Caffeine and alcohol both affect sleep architecture and both change during a period of…
NHS criteria and how they are applied in practice — the long version Replied, post #13 · Regional › UK & Ireland · 25 Oct 2025 · 17 likes NHS criteria would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Follow-up: What a seizure notice actually says Replied, post #3 · Sourcing › Logistics · 23 Oct 2025 · 0 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
Sleep tracking data and its considerable limitations Replied, post #19 · Wellbeing › Sleep · 17 Oct 2025 · 9 likes The failure mode on sleep is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
Documentation that materially improves an appeal's chances Replied, post #22 · Access › Insurance & coverage · 8 Oct 2025 · 3 likes Clear enough that I do not think I have a follow-up, which is unusual.
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #82 · Lounge › Off topic · 8 Oct 2025 · 0 likes Non-technical and offered in the right category: the best thing about a forum with no vote score is that the boring accurate answer sits at the same level as the…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #84 · Practice › Side effects · 22 Sep 2025 · 0 likes Taking post #81 at face value and following it one step further. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #61 · Practice › Side effects · 14 Sep 2025 · 4 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Why oral semaglutide needs an absorption enhancer at all Replied, post #33 · Compounds › Oral incretins · 13 Sep 2025 · 17 likes Taking the oral product with more water than instructed reduces absorption rather than helping it. That is counter-intuitive and it is one of the few dosing…
Analytical identity of BPC-157: a 15-mer with a simple mass Replied, post #5 · Compounds › Repair & healing peptides · 2 Sep 2025 · 6 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #48 · Sourcing › Vendor reports · 30 Aug 2025 · 0 likes I had written a reply contradicting post #44 and deleted it. Here is what survived. My understanding of vendor documentation pages is a few years old and may have been…
Tracking that stops updating and then resumes — the long version Replied, post #9 · Sourcing › Logistics · 28 Aug 2025 · 4 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #3 · marked as the solution · Evidence › Journal club · 19 Aug 2025 · 22 likes Answering the question the opening post raises rather than the one it answers. Where the group cannot agree, record the disagreement rather than resolving it by…
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #20 · Practice › Storage & stability · 5 Aug 2025 · 4 likes The honest summary: keep it dry until you need it, keep it cold once it is not, keep it dark, do not cycle the temperature, and treat any period at room temperature as…
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #6 · Practice › Storage & stability · 13 Jul 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. The mechanism is…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #119 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2025 · 16 likes Combination products complicate the certificate question considerably. Two active components mean two purity determinations and a ratio, and a single figure for a…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #29 · Nutrition & Training › Protein & intake · 6 Jun 2025 · 2 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #119 · Evidence › Journal club · 22 Apr 2025 · 3 likes Picking up post #118: that is the part I would want checked first. What I would tell a new member reading about STEP 1 for the first time: the confident posts are not…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #81 · Devices › Cold chain · 8 Apr 2025 · 13 likes I read post #77 twice before replying, because I had assumed the opposite. Repacking cold material into a domestic refrigerator promptly on arrival is the one step that…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #15 · Evidence › Journal club · 27 Mar 2025 · 0 likes Where I part company with post #11, and it is a narrow parting. Reading order that works for these sessions: registry entry, methods, baseline table, primary result,…
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #7 · Sourcing › Vendor reports · 19 Mar 2025 · 0 likes Coming back to post #5, because the follow-up matters more than the original answer. Reports of ordinary results are more valuable than reports of remarkable ones,…
Validating a method you did not develop — does this still hold? Replied, post #127 · Analytics › Method validation · 17 Mar 2025 · 1 like Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
Charge states for a 4 kDa peptide, worked through Replied, post #118 · Analytics › Mass spectrometry · 15 Mar 2025 · 5 likes The most useful thing anyone has posted about charge states in this category was a table of what had been measured and by whom. That is what I would want again.
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #3 · Practice › Interactions · 27 Feb 2025 · 0 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #6 · Pharmacology › Receptor biology · 24 Feb 2025 · 1 like Glucagon receptor agonism raises energy expenditure and promotes hepatic fat oxidation. In a triple agonist the incretin limbs offset the glycaemic consequence, which…
Canadian access and provincial variation Replied, post #39 · Regional › North America · 31 Jan 2025 · 30 likes Everything in post #36 holds. The case it does not cover is the one I have. Indigenous healthcare systems: different indigenous healthcare systems have different…
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #10 · Regional › UK & Ireland · 13 Jan 2025 · 2 likes Pharmacy supply is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #17 · Compounds › Semaglutide · 19 Dec 2024 · 5 likes An update on my earlier Semaglutide formulation post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #42 · Practice › Reconstitution · 10 Dec 2024 · 0 likes Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the foaming that makes people think something has gone wrong.…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #60 · Access › Insurance & coverage · 8 Dec 2024 · 0 likes Marking my uncertainty on Step therapy requirements explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #13 · Evidence › Journal club · 7 Dec 2024 · 17 likes Post #10 is the version of this I will quote in future. One addition. The reason STEP 4 keeps being re-asked is that the answer is conditional and people quote it…
When to suspect the method rather than the sample Replied, post #46 · Analytics › Method validation · 5 Dec 2024 · 9 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.
Coming back to: When to suspect the method rather than the sample Replied, post #23 · Analytics › Method validation · 3 Dec 2024 · 0 likes I had written a reply contradicting post #21 and deleted it. Here is what survived. Specificity: the method can distinguish the intended compound from related…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #161 · Compounds › Repair & healing peptides · 27 Nov 2024 · 22 likes Post #157 put the caveat in the right place and I want to underline it. I have three months of notes on reading a preclinical wound-healing model and the honest summary…
EMA product information as a primary source — does this still hold? Replied, post #5 · Regional › European Union · 14 Nov 2024 · 5 likes Agreed, and I will stop repeating the version of this I had been repeating.
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #109 · Compounds › Other compounds · 11 Nov 2024 · 16 likes Melanotan II is a non-selective melanocortin agonist, which is why its effects are not confined to pigmentation. The non-selectivity is the mechanism and not a side…
SURPASS-2 and the comparator dose question that will not go away Replied, post #50 · Compounds › Tirzepatide · 6 Nov 2024 · 6 likes SURPASS-2 is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #52 · Compounds › Other compounds · 15 Oct 2024 · 0 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #71 · Clinical › Prescriber conversations · 5 Oct 2024 · 1 like Where you have a specific worry, name it. "I am worried about X" is more useful to a clinician than a series of questions circling X.
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #53 · Sourcing › Independent verification · 12 Sep 2024 · 0 likes I had written a reply contradicting post #49 and deleted it. Here is what survived. Repeat testing: if you want to verify the same lot a second time, testing with a…
Assessing a warm arrival: the decision process — one year on Replied, post #64 · Sourcing › Logistics · 31 May 2024 · 10 likes The same route behaves differently in different months. A single good or bad experience is one sample from a distribution. The disagreement above is smaller than it…
Where the four-week escalation interval comes from, and what it is not Replied, post #7 · Practice › Dosing & titration · 27 May 2024 · 27 likes That is a cleaner way of putting what I was circling around.